Logo image of PHIA.AS

KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:PHIA - NL0000009538 - Common Stock

23.24 EUR
-0.06 (-0.26%)
Last: 12/9/2025, 5:36:15 PM
Fundamental Rating

3

Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 63 industry peers in the Health Care Equipment & Supplies industry. PHIA may be in some trouble as it scores bad on both profitability and health. PHIA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
In multiple years PHIA reported negative net income over the last 5 years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

PHIA has a worse Return On Assets (0.61%) than 63.49% of its industry peers.
PHIA's Return On Equity of 1.56% is on the low side compared to the rest of the industry. PHIA is outperformed by 63.49% of its industry peers.
PHIA has a Return On Invested Capital of 4.27%. This is comparable to the rest of the industry: PHIA outperforms 41.27% of its industry peers.
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROIC 4.27%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

PHIA's Profit Margin of 0.91% is on the low side compared to the rest of the industry. PHIA is outperformed by 63.49% of its industry peers.
PHIA has a Operating Margin (6.11%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of PHIA has declined.
The Gross Margin of PHIA (43.85%) is worse than 73.02% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
Industry RankSector Rank
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
Compared to 1 year ago, PHIA has less shares outstanding
The number of shares outstanding for PHIA has been increased compared to 5 years ago.
PHIA has a worse debt/assets ratio than last year.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

PHIA has an Altman-Z score of 1.90. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
PHIA has a worse Altman-Z score (1.90) than 61.90% of its industry peers.
The Debt to FCF ratio of PHIA is 19.41, which is on the high side as it means it would take PHIA, 19.41 years of fcf income to pay off all of its debts.
PHIA has a Debt to FCF ratio (19.41) which is in line with its industry peers.
A Debt/Equity ratio of 0.69 indicates that PHIA is somewhat dependend on debt financing.
PHIA has a worse Debt to Equity ratio (0.69) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Altman-Z 1.9
ROIC/WACC0.66
WACC6.47%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.26 indicates that PHIA should not have too much problems paying its short term obligations.
PHIA has a Current ratio of 1.26. This is in the lower half of the industry: PHIA underperforms 63.49% of its industry peers.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a Quick ratio of 0.81. This is in the lower half of the industry: PHIA underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.81
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.15% over the past year.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
The Revenue has decreased by -0.81% in the past year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%

3.2 Future

Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.05% on average per year.
PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.41% yearly.
EPS Next Y3.9%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
EPS Next 5Y13.05%
Revenue Next Year-1.88%
Revenue Next 2Y0.58%
Revenue Next 3Y1.85%
Revenue Next 5Y3.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.70, the valuation of PHIA can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 95.24% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. PHIA is valued slightly cheaper when compared to this.
PHIA is valuated correctly with a Price/Forward Earnings ratio of 15.06.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.56.
Industry RankSector Rank
PE 15.7
Fwd PE 15.06
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 76.19% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PHIA.
Industry RankSector Rank
P/FCF 51.56
EV/EBITDA 12.17
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.02
PEG (5Y)N/A
EPS Next 2Y5.55%
EPS Next 3Y8.25%

0

5. Dividend

5.1 Amount

PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KONINKLIJKE PHILIPS NV

AMS:PHIA (12/9/2025, 5:36:15 PM)

23.24

-0.06 (-0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners44.69%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap22.38B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.64 (18.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.91%
PT rev (3m)0.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.38%
EPS NY rev (1m)3.66%
EPS NY rev (3m)2.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 15.7
Fwd PE 15.06
P/S 1.25
P/FCF 51.56
P/OCF 20.36
P/B 2.16
P/tB N/A
EV/EBITDA 12.17
EPS(TTM)1.48
EY6.37%
EPS(NY)1.54
Fwd EY6.64%
FCF(TTM)0.45
FCFY1.94%
OCF(TTM)1.14
OCFY4.91%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)4.02
PEG (5Y)N/A
Graham Number18.95
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROCE 5.69%
ROIC 4.27%
ROICexc 4.72%
ROICexgc 15.5%
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
FCFM 2.43%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Debt/EBITDA 3.01
Cap/Depr 51.35%
Cap/Sales 3.72%
Interest Coverage 4
Cash Conversion 46.06%
Profit Quality 267.9%
Current Ratio 1.26
Quick Ratio 0.81
Altman-Z 1.9
F-Score8
WACC6.47%
ROIC/WACC0.66
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y3.9%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
EPS Next 5Y13.05%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-1.88%
Revenue Next 2Y0.58%
Revenue Next 3Y1.85%
Revenue Next 5Y3.41%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.79%
EBIT Next 3Y20.32%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NV / PHIA.AS FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


Can you provide the valuation status for KONINKLIJKE PHILIPS NV?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NV?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.


What is the expected EPS growth for KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 3.9% in the next year.